CN107348480A - Walnut oil microcapsule albumen powder - Google Patents
Walnut oil microcapsule albumen powder Download PDFInfo
- Publication number
- CN107348480A CN107348480A CN201710356226.9A CN201710356226A CN107348480A CN 107348480 A CN107348480 A CN 107348480A CN 201710356226 A CN201710356226 A CN 201710356226A CN 107348480 A CN107348480 A CN 107348480A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- walnut oil
- oil microcapsule
- microcapsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 80
- 239000000843 powder Substances 0.000 title claims abstract description 72
- 235000019498 Walnut oil Nutrition 0.000 title claims abstract description 53
- 239000008170 walnut oil Substances 0.000 title claims abstract description 53
- 239000000944 linseed oil Substances 0.000 claims abstract description 22
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 239000003921 oil Substances 0.000 claims abstract description 9
- 235000019198 oils Nutrition 0.000 claims abstract description 9
- 239000005862 Whey Substances 0.000 claims abstract description 8
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 8
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 8
- 241000758789 Juglans Species 0.000 claims abstract description 7
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 7
- 235000012680 lutein Nutrition 0.000 claims abstract description 7
- 239000001656 lutein Substances 0.000 claims abstract description 7
- 229960005375 lutein Drugs 0.000 claims abstract description 7
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 7
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 7
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 7
- 235000020234 walnut Nutrition 0.000 claims abstract description 7
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 5
- 239000000787 lecithin Substances 0.000 claims abstract description 5
- 229940067606 lecithin Drugs 0.000 claims abstract description 5
- 235000010445 lecithin Nutrition 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 24
- 229920000858 Cyclodextrin Polymers 0.000 claims description 9
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 9
- 229920002774 Maltodextrin Polymers 0.000 claims description 7
- 239000005913 Maltodextrin Substances 0.000 claims description 7
- 229940035034 maltodextrin Drugs 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000020357 syrup Nutrition 0.000 claims description 6
- 238000004945 emulsification Methods 0.000 claims description 5
- 239000003292 glue Substances 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 206010011732 Cyst Diseases 0.000 claims 2
- 208000031513 cyst Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 6
- 125000001931 aliphatic group Chemical group 0.000 abstract description 4
- 230000013872 defecation Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 235000020256 human milk Nutrition 0.000 abstract description 3
- 210000004251 human milk Anatomy 0.000 abstract description 3
- 235000020778 linoleic acid Nutrition 0.000 abstract description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 210000004958 brain cell Anatomy 0.000 abstract 1
- 230000011712 cell development Effects 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract 1
- 239000010931 gold Substances 0.000 abstract 1
- 229910052737 gold Inorganic materials 0.000 abstract 1
- 230000004491 retinal development Effects 0.000 abstract 1
- 206010010774 Constipation Diseases 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention provides walnut oil microcapsule albumen powder, it is made from the following raw materials in parts by weight：0.1 0.5 parts of 30 50 parts of walnut oil microcapsule powder, 10 20 parts of linseed oil microcapsule powder, 5 15 parts of PURE WHEY, 5 15 parts of walnut powder, 5 15 parts of DHA algal oil, 15 parts of lecithin and lutein.A kind of walnut oil microcapsule albumen powder provided by the invention, has no toxic side effect.Walnut oil contains substantial amounts of unrighted acid, because acidity is low and fresh pollution-free, it is possible to reduce to the cushion effect of baby's stomach, burden aliphatic acid configuration will not be caused to be classified as 1 close to gold ratio close to breast milk, Ω 3, the fatty acid proportions of Ω 6 to baby's internal organs:4, DHA can be formed by being converted after absorption of human body, promote human body brain cell development and retinal development.Its Linoleic acid can relax bowel, the problem of avoiding traditional supplementary calcium food from causing poor children's absorbability, stimulating intestine and stomach, difficult defecation.
Description
Technical field
The present invention relates to health food, more particularly to walnut oil microcapsule albumen powder.
Background technology
Albumen powder is a kind of nourishment food replenishers for specific crowd.Can be baby as amino acid supplementation food
Child, old man, sport people, preoperative and postoperative patient and people to lose weight are provided because of nutrition necessary to protein loss offer.And show
Poor with the presence of albumen powder absorbability, nutrition is single, constipation is easily caused after use, the problem of storage time is short.
The content of the invention
For the drawbacks described above and problem of prior art, the purpose of the embodiment of the present invention is to provide a kind of more nutrient mixed modes
Walnut oil microcapsule albumen powder.
In order to achieve the above object, the present invention provides following technical scheme：Walnut oil microcapsule albumen powder, by following weight
The raw material of part is made：Walnut oil microcapsule powder 45-55 parts, linseed oil microcapsule powder 10-20 parts, PURE WHEY 5-15 parts,
Walnut powder 5-15 parts, DHA algal oil 5-15 parts, lecithin 1-5 parts and lutein 0.1-0.5 parts.
Wherein, it is made up of following optimal proportion raw material：50 parts of walnut oil microcapsule powder, 15 parts of linseed oil microcapsule powder,
0.2 part of 10 parts of PURE WHEY, 10 parts of walnut powder, 10 parts of DHA algal oil, 5 parts of lecithin and lutein.
Wherein, the microcapsule wall material of walnut oil microcapsule powder passes through emulsification investment fashion system by the raw material of following parts by weight
Into：1 part of glucose syrup, 1 part of casein, 1 part of maltodextrin and cyclodextrine 0.3-0.9 parts.
Wherein, the microcapsule wall material of walnut oil microcapsule powder passes through emulsification investment fashion system by the raw material of following parts by weight
Into：0.35 part of 1 part of glucose syrup, 1 part of casein, 1 part of maltodextrin and cyclodextrine.
Wherein, the microcapsule wall material of walnut oil microcapsule powder is dried using spray dried form.
Wherein, the walnut oil core of walnut oil microcapsule powder and microcapsule wall material mass ratio are 1:2~4.
Wherein, the walnut oil core of walnut oil microcapsule powder and microcapsule wall material mass ratio are 1:3.33.
Wherein, it is characterised in that the microcapsule wall material of linseed oil microcapsule powder passes through molecule by the raw material of following parts by weight
Complexing mode is made：1 part of gelatin, 1 portion of cyclodextrine, 1 part of phase maltodextrin.
Wherein, the microcapsule wall material of linseed oil microcapsule powder is dried using freeze-day with constant temperature mode.
Wherein, the linseed oil core of linseed oil microcapsule powder and microcapsule wall material mass ratio are 1:1.6.
A kind of walnut oil microcapsule albumen powder provided by the invention, has no toxic side effect.Walnut oil contains substantial amounts of unsaturation
Aliphatic acid, because acidity is low and fresh pollution-free, it is possible to reduce to the cushion effect of baby's stomach, baby's internal organs will not be caused
Bear aliphatic acid configuration close to breast milk and Ω -3, Ω -6 fatty acid proportion be 1:1 is easily digested and assimilated by baby.Its Central Asia oil
Acid can relax bowel, the problem of avoiding traditional supplementary calcium food from causing poor children's absorbability, stimulating intestine and stomach, difficult defecation.Ω -3 has
Mitigation allergic reaction is helped, to treating and preventing arthritis from having very big effect.60% rheumathritis patient receives Ω -3, Ω -6 fat
After fat acid treatment, the anti-inflammatory drug of edible on-steroidal can be stopped completely, and have 20% secondary can to resist on-steroidal in addition
Scorching medicine halves, and avoiding taking albumen powder causes aggravation problem caused by ventilation or arthritic.
Embodiment
Below in conjunction with embodiments of the invention, technical scheme is clearly and completely described, it is clear that
Described embodiment is only part of the embodiment of the present invention, rather than whole embodiments.Based on the implementation in the present invention
Example, the every other embodiment that those of ordinary skill in the art are obtained under the premise of creative work is not made, is belonged to
The scope of protection of the invention.
As embodiment, walnut oil microcapsule albumen powder, the raw material by following parts by weight is by being sufficiently mixed, low-temperature mixed
Powder is made in drying：Walnut oil microcapsule powder 45-55 parts, linseed oil microcapsule powder 10-20 parts, PURE WHEY 5-15
Part, walnut powder 5-15 parts, DHA algal oil 5-15 parts, -5 parts of soft phosphatidase 1 and lutein 0.1-0.5 parts.Containing substantial amounts of in walnut oil
Unrighted acid, because acidity is low and fresh pollution-free, it is possible to reduce, will not be to internal organs in baby to the cushion effect of baby's stomach
Official cause to bear aliphatic acid configuration close to breast milk and Ω -3, Ω -6 fatty acid proportion be 1:1 easily by children digest and assimilate its
Linoleic acid can relax bowel.The phenomenon of difficult defecation is easily caused in edible by synergy solution milk calcium and milk powder.Core
Peach oil can promote calcium uptake to help bone and dental growth rich in natural vitamin A, D.Walnut oil microcapsule powder is relative to walnut
Oil is more conducive to children and absorbed, and does not stimulate children's stomach.And grown with the holding time, the advantages of should not aoxidizing.Linseed oil is selected
The linseed of Gansu production, is extracted by cold press, higher with the alpha-linolenic acid in the linseed of Gansu production and linoleic acid content, generally
Respectively reach 56.30%, 25.70%.Linseed oil has improvement intestines and internal organs of the body function, increases absorbability, increases the wriggling of intestines
Ability makes defecation normal, reduces the function of constipation.Pass through linseed oil microcapsule powder, walnut oil microcapsule powder and lactalbumin
Powder cooperates.When reducing children and being supplemented using PURE WHEY, caused constipation, absorb it is insufficient, situations such as digestive discomfort.
In one embodiment, it is made up of following optimal proportion raw material：50 parts of walnut oil microcapsule powder, the micro- glue of linseed oil
0.2 part of 15 parts of capsule powder, 10 parts of PURE WHEY, 10 parts of walnut powder, 10 parts of DHA algal oil, soft phosphatidase 5 part and lutein.
In one embodiment, in order to ensure to obtain more preferably color and luster, granularity and embedding rate, walnut oil microcapsule powder
Microcapsule wall material is made up of the raw material of following parts by weight by emulsification investment fashion：1 part of glucose syrup, 1 part of casein, malt
1 part of dextrin and cyclodextrine 0.3-0.9 parts.
In one embodiment, preferably, the microcapsule wall material of walnut oil microcapsule powder by following parts by weight raw material
It is made by emulsifying investment fashion：0.35 part of 1 part of glucose syrup, 1 part of casein, 1 part of maltodextrin and cyclodextrine.
In one embodiment, the microcapsule wall material of walnut oil microcapsule powder is dried using spray dried form, and charging is dense
It is 160-180 DEG C to spend for 20%-30%, 50-60 DEG C of feeding temperature, EAT, and leaving air temp is 70-80 DEG C.
In one embodiment, it is the abundant embedding rate of guarantee, the walnut oil core and microcapsule wall of walnut oil microcapsule powder
Material mass ratio is 1:2~4.
In one embodiment, as optimal selection, walnut oil core and the microcapsule wall material of walnut oil microcapsule powder
Amount is than being 1:3.33.
In one embodiment, in order to ensure to obtain more preferably color and luster, granularity and embedding rate, linseed oil microcapsule powder
Microcapsule wall material be made up of the raw material of following parts by weight by molecular complex mode：1 part of 1 part of gelatin, cyclodextrine phase malt
1 part of dextrin.
In one embodiment, the microcapsule wall material of linseed oil microcapsule powder is dried using freeze-day with constant temperature mode, is dried
Temperature is 50-70 DEG C.
In one embodiment, in order to ensure to obtain more preferably color and luster, granularity and embedding rate, linseed oil microcapsule powder
Linseed oil core and microcapsule wall material mass ratio be 1:1.6.
The foregoing is only a specific embodiment of the invention, but protection scope of the present invention is not limited thereto, any
Those familiar with the art the invention discloses technical scope in, change or replacement can be readily occurred in, should all be contained
Cover within protection scope of the present invention.Therefore, protection scope of the present invention described should be defined by scope of the claims.
Claims (10)
1. walnut oil microcapsule albumen powder, it is characterised in that be made from the following raw materials in parts by weight：Walnut oil microcapsule powder 30-50
Part, linseed oil microcapsule powder 10-20 parts, PURE WHEY 5-15 parts, walnut powder 5-15 parts, DHA algal oil 5-15 parts, lecithin
1-5 parts and lutein 0.1-0.5 parts.
2. walnut oil microcapsule albumen powder according to claim 1, it is characterised in that be made up of following optimal proportion raw material：
50 parts of walnut oil microcapsule powder, 15 parts of linseed oil microcapsule powder, 10 parts of PURE WHEY, 10 parts of walnut powder, DHA algal oil 10
0.2 part of part, 5 parts of lecithin and lutein.
3. walnut oil microcapsule albumen powder according to claim 2, it is characterised in that the microcapsules of walnut oil microcapsule powder
Wall material is made up of the raw material of following parts by weight by emulsification investment fashion：1 part of glucose syrup, 1 part of casein, 1 part of maltodextrin
And cyclodextrine 0.3-0.9 parts.
4. walnut oil microcapsule albumen powder according to claim 3, it is characterised in that micro- glue of walnut oil microcapsule powder
Cyst wall material is made up of the raw material of following parts by weight by emulsification investment fashion：1 part of glucose syrup, 1 part of casein, maltodextrin 1
0.35 part of part and cyclodextrine.
5. the walnut oil microcapsule albumen powder according to claim 3 or 4, it is characterised in that walnut oil microcapsule powder it is micro-
Capsule wall material is dried using spray dried form.
6. walnut oil microcapsule albumen powder according to claim 5, it is characterised in that the walnut oil of walnut oil microcapsule powder
Core is 1 with microcapsule wall material mass ratio:2~4.
7. walnut oil microcapsule albumen powder according to claim 6, it is characterised in that the walnut oil of walnut oil microcapsule powder
Core is 1 with microcapsule wall material mass ratio:3.33.
8. walnut oil microcapsule albumen powder according to claim 1, it is characterised in that it is characterized in that the micro- glue of linseed oil
The microcapsule wall material of capsule powder is made up of the raw material of following parts by weight by molecular complex mode：1 part of gelatin, 1 part of phase of cyclodextrine
1 part of maltodextrin.
9. walnut oil microcapsule albumen powder according to claim 8, it is characterised in that micro- glue of linseed oil microcapsule powder
Cyst wall material is dried using freeze-day with constant temperature mode.
10. walnut oil microcapsule albumen powder according to claim 9, it is characterised in that the Asia of linseed oil microcapsule powder
Flaxseed oil core is 1 with microcapsule wall material mass ratio:1.6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710356226.9A CN107348480A (en) | 2017-05-19 | 2017-05-19 | Walnut oil microcapsule albumen powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710356226.9A CN107348480A (en) | 2017-05-19 | 2017-05-19 | Walnut oil microcapsule albumen powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107348480A true CN107348480A (en) | 2017-11-17 |
Family
ID=60271635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710356226.9A Pending CN107348480A (en) | 2017-05-19 | 2017-05-19 | Walnut oil microcapsule albumen powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107348480A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109123660A (en) * | 2018-09-17 | 2019-01-04 | 山西欧莱特农业科技有限公司 | A kind of walnut lactalbumin composite powder and preparation method thereof for maternal nutritional product |
| CN109123659A (en) * | 2018-09-17 | 2019-01-04 | 山西欧莱特农业科技有限公司 | A kind of walnut protein composite powder and preparation method thereof for diatery supplement nutriment |
| CN109601988A (en) * | 2019-01-24 | 2019-04-12 | 金果园老农（北京）食品股份有限公司 | A kind of microcapsule powder, food supplement for children nutrition and preparation method thereof |
| CN110973634A (en) * | 2019-12-25 | 2020-04-10 | 德瑞美医药生物技术盐城有限公司 | Nutritional composition for improving hypoevolutism and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102763764A (en) * | 2012-08-03 | 2012-11-07 | 隆尧今野调味品有限公司 | Method for preparing chicken bone collagen powder |
| CN103315299A (en) * | 2013-07-08 | 2013-09-25 | 北京东方红航天生物技术股份有限公司 | Health-care food with function of enhancing immunity and memory |
| CN103549442A (en) * | 2013-11-01 | 2014-02-05 | 厦门汇盛生物有限公司 | High-oil-load DHA (docosahexaenoic acid) algae oil microcapsule powder and preparation technique thereof |
| CN105076403A (en) * | 2014-05-07 | 2015-11-25 | 保龄宝生物股份有限公司 | Dental caries resistant milk product containing erythritol |
| CN105230811A (en) * | 2015-11-11 | 2016-01-13 | 嘉必优生物工程（武汉）有限公司 | High oil whey powder containing polyunsaturated fatty acid fat |
| CN105614764A (en) * | 2015-12-29 | 2016-06-01 | 广东省农业科学院蚕业与农产品加工研究所 | Preparation method of mulberry nanometer microcapsule and nutrition powder prepared from mulberry nanometer microcapsule |
| CN105996040A (en) * | 2016-05-20 | 2016-10-12 | 福建师范大学 | Microcapsule powder and preparation method thereof |
-
2017
- 2017-05-19 CN CN201710356226.9A patent/CN107348480A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102763764A (en) * | 2012-08-03 | 2012-11-07 | 隆尧今野调味品有限公司 | Method for preparing chicken bone collagen powder |
| CN103315299A (en) * | 2013-07-08 | 2013-09-25 | 北京东方红航天生物技术股份有限公司 | Health-care food with function of enhancing immunity and memory |
| CN103549442A (en) * | 2013-11-01 | 2014-02-05 | 厦门汇盛生物有限公司 | High-oil-load DHA (docosahexaenoic acid) algae oil microcapsule powder and preparation technique thereof |
| CN105076403A (en) * | 2014-05-07 | 2015-11-25 | 保龄宝生物股份有限公司 | Dental caries resistant milk product containing erythritol |
| CN105230811A (en) * | 2015-11-11 | 2016-01-13 | 嘉必优生物工程（武汉）有限公司 | High oil whey powder containing polyunsaturated fatty acid fat |
| CN105614764A (en) * | 2015-12-29 | 2016-06-01 | 广东省农业科学院蚕业与农产品加工研究所 | Preparation method of mulberry nanometer microcapsule and nutrition powder prepared from mulberry nanometer microcapsule |
| CN105996040A (en) * | 2016-05-20 | 2016-10-12 | 福建师范大学 | Microcapsule powder and preparation method thereof |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109123660A (en) * | 2018-09-17 | 2019-01-04 | 山西欧莱特农业科技有限公司 | A kind of walnut lactalbumin composite powder and preparation method thereof for maternal nutritional product |
| CN109123659A (en) * | 2018-09-17 | 2019-01-04 | 山西欧莱特农业科技有限公司 | A kind of walnut protein composite powder and preparation method thereof for diatery supplement nutriment |
| CN109123660B (en) * | 2018-09-17 | 2021-07-23 | 山西欧莱特农业科技有限公司 | Walnut whey protein composite powder for pregnant woman nutriments and preparation method thereof |
| CN109123659B (en) * | 2018-09-17 | 2021-07-23 | 山西欧莱特农业科技有限公司 | Walnut protein composite powder for supplementary food nutrition supplement and preparation method thereof |
| CN109601988A (en) * | 2019-01-24 | 2019-04-12 | 金果园老农（北京）食品股份有限公司 | A kind of microcapsule powder, food supplement for children nutrition and preparation method thereof |
| CN110973634A (en) * | 2019-12-25 | 2020-04-10 | 德瑞美医药生物技术盐城有限公司 | Nutritional composition for improving hypoevolutism and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107348480A (en) | Walnut oil microcapsule albumen powder | |
| CN109965026A (en) | A kind of formula milk and preparation method thereof promoting child growth | |
| CN108812909A (en) | A kind of improvement partial eclipse or the diatery supplement nutriment of anorexia and preparation method thereof | |
| CN110037127A (en) | A kind of probiotics preparation and preparation method thereof improving infant's enteron aisle | |
| CN104784668B (en) | A kind of Lactogenic soup and preparation method thereof | |
| CN103609696A (en) | Intelligence-promoting eyesight-improving type yoghourt and processing method thereof | |
| CN101579126A (en) | Special meal nutritional food used for rehabilitation after partum and artificial abortion | |
| CN103070242A (en) | Formula goat milk powder for pregnant women and preparation method of formula goat milk powder | |
| CN102994346A (en) | Base stock for preparing MACA wine | |
| CN110037113A (en) | A kind of Ms's weight reducing face-beautifying milk powder | |
| CN113632851A (en) | Multifunctional children growth milk powder and preparation method thereof | |
| CN105053680A (en) | Immunity enhancing nursing concentrated feed | |
| CN107334156A (en) | Lactagogue full nutrition formula food | |
| CN107050409A (en) | A kind of herbal composite for adjusting intestine of young pigs health and preparation method and application | |
| CN103750293A (en) | Plant type milk powder mate and preparation method thereof | |
| CN109007355A (en) | A kind of functional feed improving malnutritional anemia | |
| CN108741086A (en) | A kind of sports tonica and preparation method thereof suitable for long-term body-building | |
| CN114190441A (en) | Formula milk powder for promoting growth and development of children and preparation method thereof | |
| CN111493312A (en) | Coffee-flavored dietary nutrition meal and preparation method thereof | |
| CN106107121A (en) | A kind of composite feed additive preventing and treating sow puerperal hypogalactia and preparation method thereof | |
| CN105941319A (en) | A forced moulting method for laying hens | |
| CN114391612B (en) | Fermented nutritional composition for improving lactation ability of sows and preparation method and application thereof | |
| CN102511875A (en) | Red jujube thick syrup applicable for postoperation people to drink | |
| CN100350846C (en) | Method for preparing sour milk contg. micron ginseng and antler etc. with tonifying-kidney and eliminating fatigue functions | |
| CN105379994A (en) | Traditional Chinese medicine feed used for improving quality of duck meat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171117 |